• Tidak ada hasil yang ditemukan

Kadar Fibrinogen Pada Penderita Penyakit Jantung Koroner yang Dilakukan Angiografi

N/A
N/A
Protected

Academic year: 2019

Membagikan "Kadar Fibrinogen Pada Penderita Penyakit Jantung Koroner yang Dilakukan Angiografi"

Copied!
8
0
0

Teks penuh

(1)

DAFTAR PUSTAKA

1. Risk score profiles. Framingham Heart Study ( Internet). 2012.

(cited 2012 Feb 5) Available from:

2. Silvia Loraine, 2006 a. Penyakit Aterosklerotik Koroner.

Patofisiologi Konsep Klinis Proses-Proses Penyakit Volume I. Edisi

VI. Penerbit Buku Kedokteran EGC Jakarta hal 576-612

3. Price SA. Prosedur diagnostik penyakit kardiovaskular. Dalam:

Wijaya C editor. Patofisiologi konsep klinis proses-proses penyakit.

Edisi 4. Jakarta: Penerbit Buku Kedokteran EGC; 1994: 515-523

4. Hollinger I. Mitinach A. Cardiac catheterization and other

radiographic examination. Pediatric Cardiac Anesthesia. 4. ed

Lippincott Williams and Walkins 2005; 7: 112-135

5. Trianti M, Xanthos T, Lacovidou N, et al. Relationship between

individual cardiovascular risk factors and localization of coronary

atherosclerotic lesions. Heart and Lung: The journal of acute and

critical care, 2010

6. Deitcher SR, Rodgers GM.Trombosis and Antitrombotic Therapy.

In: Greer JP, Foerster J, Lukens JN, et al. Wintrobe”s Clinical

Hematology. 11th

7. McKay J, George AM, Shantu M. Kurt G. The atlas of Heart

Disease and Stroke. WHO.Geneva; 2004

ed Lippincott Williams and Wilkins. USA. 2004:

(2)

8. Hasan R. Obat – obat anti agregasi trombosit pada PJK, UPF Ilmu

Penyakit Dalam FK – USU / RSUP H. Adam Malik Medan, 1997 : 1

– 5

9. Irmalita. Infark Miokard. Dalam buku ajar Kardiologi. FKUI. Jakarta,

1996:173-77

10. Setiabudy R. Patofisiology thrombosis; dalam hemostasis dan

thrombosis. Patologi Klinik FKUI/ RSCM. Jakarta, 1992:26-35

11. Kamath S, Lip GYH. Fibrinogen: biochemistry, epidemiology, and

determinants. Hemostasis Thrombosis and Vascular Biology.

University of Medicine Birmingham, 2003: 712-23

12. Harjai KJ. Potential New Cardiovascular Risk Factors: Left

Ventricular Hyperthrophy, Homocystein, Lipoprotein (a),

Triglycerides, Oxidative Stress and Fibrinogen. Annal of Internal

Medicine, 1999; 131 (5): 376-86

13. Tarrallo P. Reference Limit of Plasma Fibrinogen. Eur. J. Clin.

Chem. Clin. Biochem, 1992; 30(11): 745-51

14. Stone MC, Thorp Jm. Plasma fibrinogen a major coronary risk

factor; J Roy Coll Gen Prac 1985: 565-9

15. Cooper J, Douglas AS. Fibrinogen Levels as a Predictor of Mortality

in Survivors of Myocardial Infarction. Fibrinolysis Vol.5 no.2,1991:

105-8

16. Lee AJ. Fibrinogen in Relation to Personal History of Prevalent

(3)

Coronary Heart Disease and Family History, The Scottisth Heart

Health Study. British Heart Journal, 1993; 69: 338-42

17. Jastrzebska M., Foltynska A., Tourbus-Lisiecka B., Chelstowski K.,

Piechul-Mroz J. et al. Fibrinogen and von Willebrand Factor Levels

in Relation to Lipid Profile and Blood Presure in Children Whose

Fathers Have a History of Premature Myocardial Infarction. Polish

Heart Journal, 2002; 6(5)

18. Green David, Foiles Nancy, Chan Cheeling et al. Elevated

fibrinogen levels and subsequent subclinical atherosclerosis: The

CARDIA Study. Atherosclerosis 202 (2009) 623 – 631

19. Thompson GR. A handbook of Hyperlipidemia. London: Merc &

Co.1990

20. Fargenbaum J. Aterosclerosis 2003. Available from

21. Widjaya DJ. Perkembangan penyelidikan Mutakhir Faktor Risiko

Stroke. Kumpulan Makalah Simposium Continuing Medical

Education The 6th

22. Marcovina SM, Koschinsky ML. Lipoprotein (a): Structure,

Measurement and Clinical Significance In: Rifai N, Warnick RG,

Dominiczak MH. Handbook of Lipoprotein Testing 2009. P: 283 –

313

Perdossi Course on Stroke. Jakarta.1999

23. Karniawati M, Lipoprotein (a). Informasi Laboratorium Prodia. 2000.

(4)

24. Packard RR, Libby P. Inflamation in atherosclerosis: from vascular

biology to biomarker discovery and risk prediction. Clin chem..

2008, p: 24 – 28

25. Hansson GK. Inflammation , atherosclerosis and coronary artery

disease. N engl J Med. 2005.p: 1685 – 95

26. Hunziker PR. Bedside quantification of atherosclerosis severity for

cardiovascular risk stratification: a prospective cohort study, J Am

Coll Cardiol. 2002; 39:702-9

27. Feskens EJ, Kromhouts D. Glucosa tolerance and risk of

cardiovascular disease: the Zutphen study. J Clin Epidemiol. 2002;

45: 1327 – 34

28. Jennings PE. The mechanism of diabetic macroangiopathy.

Diabetographia. International Medical Publication 2003; 11: 4 – 6

29. Osterud B, Bjorklid E. Role of monocytes in atherogenesis.

Department of Biochemistry, Institude of Medical biology, Faculty

of Medicine University of Tiomso, Norway. 2003. P: 1077 – 8

30. Hills L.D. and Braundwald; E: Coronary - artery Spasm. N. Engl. J.

Med 2001; 299: 695

31. Davies, M. J. Intramyocardial platelets aggregation in patient with

unstable angina suffering sudden ischemic cardiac death.

Circulation. 2001; 73: 418

32. Fahey VA and Riegel BJ: Advances in diagnostic testing for

(5)

33. Mannering D, Bennett ED, Ward DE, Dawkins K, Dancy M,

Valantine H, et al. Accurate detection of triple vessel disease in

patients with exercise induced ST segment depression after

infarction. Br Heart J; 1987:57:133-8

34. Goodnight SH., Hathaway WE. Abnormalities of fibrinogen In

Disorders of Hemostasis and Trombosis A Clinical Guide. Ed. 2. Mc

Graw Hill companies Ne 2001; 18: 175 – 78

35. Greenberg CS., Orthner CL. Blood Coagulation and Fibrinolysis in

Wintrobe’s Clinical Haematology 9th

36. Hoffman R, Benz EJ, Shattil SJ, Furie B, Silberstein LE, McGlave P,

Heslop H. Hematology: Basic principles and practice. 5rd ed.

Philadelphia 2007: Churcill Livingstone Inc. p: 1827, 2046-7

ed. Lippincott Williams &

Wilkins. Philadelphia, 2002:495

37. Mosesson MW. Fibrinogen & Fibrin Polymerization: The Binding

Events That Accompanya Fibrin Generation and Fibrin Clot

Assembly. Blood Coagulation Fibrinolisis. 1997. P : 257 - 67

38. Giangrande PLF. Fibrinogen Deficiency 2010, available at:

39. Ziedins KB, Orfeo T, Jenny NS, et al. Blood Coagulation and

Fibrinolisis. In: Greer JP, et al, (Eds). Wintrobe’s Clinical

Haematology, 11 th

40. Browse MS. Fibrinogen Medical Encyclopedia, Verimed heathcare

Network 2011

(6)

41. Cote HCF, Lord ST, Pratt KP.y – Chain Dysfibrinogemias:

Molecular Structure – Function Relationship of naturally Occuring

Mutations in the y Chain of Human Fibrinogen. The Journal Of The

American Society of Haematology, Oct 1998:92(7)

42. Roberts HR, Monroe DM, Hoffman M. Molecular Biochemistry Of

The Coagulation Factors and Pathways of Haemostasis. In: Beutler

E, Litchman MA, Coller BS, Kipps TJ, Eds. Williams Haematology,

6 th

43. Richard A, Mc Person. Specific Protein. In: Davey FR, Nakamura

RM Eds. Henry JB. Clinical Diagnosis by Laboratory Methods

Philadelphia, 19

ed. New York: Mc Graw Hill, 2001: :1423-5

th

44. Ernst E, Resch KL. Fibrinogen as a Cardiovascular Risk factor A

Meta – Analysis and Review of the Literature. European heart

journal 1993; 118: 956-63

ed WB Saunders Company, 1996;237-240

45. Stecc JJ, Silbershatz H. Association of Fibrinogen with

Cardiovascular Risk Faktor and Cardiovascular diseases In the

Framingham Offspring Population. Circulation 2000; 1634-38

46. Smith EB. Fibrinogen, fibrin and fibrin degradation product

inrealition to atherosclerosis. Clin Haematol 1986; Vol 15: 355-70

47. Ross, Epstein FH. Atherosclerosis an inflammatory disease. N Engl

(7)

48. Kannel WB, Wolf PA, Castell, Agostino RB. Fibrinogen and risk of

cardiovascular diseases. The Framingham Study In The Journal of

the American Medical Association 1987; Vol.258: 1-15

49. Nito I. Correlation between Cortisol level and myocardial infarction

mortality among ICCU patients during first seven days in hospital.

Acta Medica Indosianna, 2004: 8-10

50. Frohlich M, Sund M. Independent association of various smoking

characteristics with markers of systemic inflammation in men In

European Heart Journal 2003; Vol 24: 1365-72

51. Martin AS, Steininger CA, Koepke J. Routine and special laboratory

evaluation of coagulation In Clinical hematology. Principles,

Procedurs, Correlation Ed 2. Lippincott Philadelphia New York

1998; 49: 639-40

52. Wood S. What’s “ normal ? “ Little consensus on CAD extent,

severity among Ontario angiographers 2011

53. Bayes-Ganis A, maleo J, Santalo M, Oliver A, Guindo J, Badimon L,

et al. Early diagnostic marker of Coronary ischaemia in patients with

chest pain. Am Heart J 2000; 140: 379-84

54. Greenberg CS, Orthner CL. Blood Coagulation and Fibrinolysis in

Wintrobe’s Clinical Hematology 9th ed.Lippincott Williams and

(8)

55. Gabay C. and Kushner I. Acute-Phase Proteins and other Systemic

Responses to Inflammation. The New England Journal of Medicine,

1999; 340(6): 448-454

56. Luc G, Bard JM, Juhan-Vague I, Ferrieres J, Evans A, Amouyel P,

Arveiler D, Fruchart JC, Ducimetiere P.C-reactive protein,

interleukin-6, and fibrinogen as predictors of coronary heart

disease: The PRIME study. Arterioscler Thromb Vasc Biol 2003;23:

1255-1261

57. Sinning JM, Bickel C, Messow CM, Schnabel R, Lubos E. Impact of

C-reactive protein and fibrinogen on cardiovascular prognosis in

patients with stable angina pectoris: the AtheroGene study.

58. Koh SCL, Biol C, Mibiol. Diagnostic Approach to Hypercoagulation

and enhanced Fibrynolisis presented at the 8th International

Congres of The Asian Society of Clinical Pathology and Laboratory

Referensi

Dokumen terkait

Disertasi Viktimisasi Politik Di Indonesia (Suatu Studi Perlindungan Hukum... ADLN Perpustakaan

terhadap sumbu lemah – z, persamaan diferensial tekuk lentur terhadap sumbu kuat – y, dan persamaan tekuk torsi terhadap pusat geser.. Titik-titik pada potongan A &

Persentase ibu nifas yang mendapat kapsul vitamin A pada persalinan anak terakhir yang lahir pada periode lima tahun terakhir tahun 2010 di Indonesia sebesar 52,2%.. Proporsi

Zakat mal adalah bagian harta yang disisihkan oleh seorang muslim atau badan yang dimiliki oleh orang muslim sesuai dengan ketentuan agama untuk diberikan kepada yang

Peta  Kesehatan  Indonesia  Tahun  2008  ini  disusun  untuk  menyediakan  beberapa  data/informasi  kesehatan  secara  garis  besar  pencapaian 

Namun, peraturan perundang-undangan tersebut tidak lagi memenuhi tuntutan pertumbuhan dan perkembangan Jakarta Ibukota Negara dan semangat desentralisasi sesuai dengan

[r]